This data sheet shows MRD Express capture performance on native cfDNA, with statistically significant detection at 10 ppm (0.001% VAF) compared with background. It also breaks down how input mass, sequencing depth, and UMI collapse stringency shape your mean target coverage, so you can plan your runs with confidence.

Covered in this data sheet

• ✓ Capture performance on native cfDNA compared with the Twist cfDNA Pan-Cancer Reference Standard v2
• ✓ How input mass, sequencing depth, and UMI stringency drive mean target coverage
• ✓ Post-capture yield equal to or higher than matched standard panels

Turnaround times are estimates only and are not guaranteed. Actual turnaround may vary based on order specifications, sample characteristics, processing requirements, operational capacity, and other applicable factors. Product information, specifications, features, availability, and timing are subject to change without notice. Twist products are for research use only. They are not intended for the diagnosis, prevention, monitoring, or treatment of a disease or condition. Twist Bioscience assumes no liability regarding the use of its products in unintended applications.